Cell Separation Technology Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global cell separation technology market is anticipated to grow at a CAGR of 10.1% during the forecast period (2023-2030). The market growth is attributed to the development of stem cell separation technologies such as Fluorescence-activated cell sorting (FACS), Magnet-activated cell sorting (MACS), pre-plating, conditioned expansion media, density gradient centrifugation, field flow fractionation (FFF), and dielectrophoresis (DEP). An increase in number of patients suffering from chronic disease and technological advancements in cell technologies. In addition, the surge in personalized medicines for early detection of disease, selection of appropriate treatment, and determination of the prognosis of the therapy drive the growth of the market.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-separation-technology-market

Isolation kits separate highly pure populations of untouched immune cells via a negative selection process that uses antibodies to recognize unwanted target cells. Without the critical step of separation (isolating biological targets like DNA, proteins, or cells from biological samples), many diagnostics and therapies would not be possible. For instance, in May 2023, Akadeum Life Sciences, in buoyancy-based cell separation and activation technology, launched a new series of products for cell therapy research and development-enabling direct leukopak human immune cell isolation and T-cell activation/expansion kits at the American Society of Gene + Cell Therapy's.

Various companies' proprietary Deterministic Cell Separation™ microfluidic technology, provides gentle separation to the cells while delivering unparalleled recovery and purity of target white blood cells. For instance, in January 2023, Curate Biosciences launched its Curate® Cell Processing System. The first-of-its-kind Curate System produces better starting materials for CAR-T cancer therapies and other cell therapies. Its exceptionally gentle microfluidic process recovers about 90.0% of white blood cells with the elimination of more than 90.0% of red cells and 99.0% of platelets from patient-sourced leukapheresis blood products.

In fields such as cell-based immunotherapy, it has been gaining recognition as a treatment for cancer and autoimmune disorders. To produce the cell therapies necessary for this treatment, there is an increasing demand for isolating cells with high purity and high viability in a sterile manner. For instance, in January 2022, Sony Corp. launched a new Cell separation System, CGX10, that sorts cells at high speed and high purity in a closed system. The CGX10's design enables the sorting of cells in a manner that is entirely closed off from the outside environment, making it possible to analyze and isolate cells while maintaining a sterile state.

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Type
o By Technology
o By Application
o By End Users
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Corning Inc., Genscript Biotech Corp., Merck KGaA, QIAGEN N.V., and Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cell Separation Technology Market Report Segment

By Type

• Instruments
• Centrifuges
• Flow Cytometers
• Filtration Systems
• Magnetic-activated Cell Separator Systems
• Consumables
• Reagents, Kits, Media, and Sera
• Beads
• Disposables

By Technology

• Gradient Centrifugation
• Surface Markers Separation
• Filtration Based Separation
• Immunodensity Cell Separation
• Others (Microfluidic Cell Separation)

By Application

• Oncology
• Neuroscience
• Stem Cell Research
• Microbiology
• Immunology

By End User

• Research Laboratories & Institutes
• Biotechnology & Biopharmaceutical Companies
• Hospitals & Diagnostic Laboratories

A full report of Cell Separation Technology Market available @ https://www.omrglobal.com/industry-reports/cell-separation-technology-market

Global Cell Separation Technology Market Report Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Akadeum Life Sciences, Inc.
• Alfa-Laval AB
• Applied Cells Inc.
• Biocompare, Inc.
• BioProcess International™
• Cell Microsystems.
• Corning Inc.
• Cytiva Life Science
• Elvesys group
• ESI Technologies Group
• IBA Lifesciences GmbH
• Miltenyi Biotec

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.